27th Annual Meeting
June 9 - 13, 2018, Lexington, KY USA

NAMS 2018 Home

Preliminary Program

Hotel Reservation

Abstract Submission

Meeting Registration

Sponsors and Exhibitors

Plenary Speakers

Dr. Mihail Barboiu, Institut Europeen des Membranes

Mihail Barboiu graduated from University Politehnica of Bucharest and received his PhD in 1998 from the University of Montpellier before spending 2 years as post-doctoral researcher at the University Louis Pasteur in Strasbourg. He is CNRS Research Leader at the Institut Europeen des Membranes in Montpellier and Fellow of Royal Society of Chemistry. Since 2014 he is also Extraordinary Professor in Sun-Yat-sen University in Guangzhou, China. A major focus of his research is Dynamic Constitutional Chemistry toward Dynamic Interactive Systems: adaptive biomimetic membranes, delivery devices etc. Author of more than 190 scientific publications, 3 books and 20 chapters and 280 conferences and lectures, Dr Barboiu has received in 2004 the EURYI Award in Chemistry and in 2015 the RSC Surfaces and Interfaces Award for the development of Artificial Water Channels. During the last ten years, Dr. Barboiu was the chair of several sessions of North American Membrane Society meetings and served on the Council of the European Membrane Society.

Dr. Rebecca Liebert, Honeywell UOP

Rebecca Liebert is president and chief executive officer of Honeywell UOP, a strategic business unit of Honeywell’s Performance Materials and Technologies division. UOP is a leading international supplier of process technology, catalysts, engineered systems, and technical and engineering services to the petroleum refining, petrochemical, and gas processing industries. The company has offices around the globe, serving customers in more than 150 countries. Prior to her current role, Rebecca served as the vice president and general manager of UOP’s Catalysts, Adsorbents and Specialties business. In 2012, she was named vice president and general manager of UOP’s Gas Processing and Hydrogen business. Before joining UOP, she was vice president and general manager for the Honeywell Electronic Materials business. Rebecca joined Honeywell in 2006 from Alcoa, Inc, where she was president of Reynolds Food Packaging, which supplies extrusion and thermoformed plastic and aluminum products to the food packaging market. Prior to this, she served as business director for the Solid Polystyrene and High Performance Polystyrene business of Nova Chemicals. Rebecca began her career at Arco Chemical Co. as a development engineer. Rebecca holds a bachelor’s degree in chemical engineering from the University of Kentucky, a doctorate in chemical engineering from Carnegie Mellon University, and an MBA from the Kellogg School of Management at Northwestern University.

Prof. Milan Mrksich, Northwestern University

Milan Mrksich is the Henry Wade Rogers Professor at Northwestern University, with appointments in the Departments of Biomedical Engineering, Chemistry, and Cell and Molecular Biology. He also serves as the Founding Director of the Center for Synthetic Biology and as an Associate Director of the Robert H. Lurie Comprehensive Cancer Center. He earned a BS degree in Chemistry from the University of Illinois and a PhD in Chemistry from Caltech. He then served as an American Cancer Society Postdoctoral Fellow at Harvard University before joining the faculty at the University of Chicago in 1996. He began his current position at Northwestern in 2011. His many honors include the Camille Dreyfus Teacher-Scholar Award, the TR100 Innovator Award, Arthur C. Cope Scholar Award, election to the American Institute for Medical and Biological Engineering and the Illinois Bio ICON Innovator Awardee. Professor Mrksich is a leader in the science and engineering of materials that contact biological environments. His laboratory has pioneered several technologies, including strategies to integrate living cells with microelectronic devices, methods to enable high throughput assays for drug discovery, and approaches to making synthetic proteins for applications as therapeutics. Professor Mrksich is an active advisor in government and industry. His present and past appointments include the Chair of the Defense Sciences Research Council—an advisory group to the Defense Department—a member of the Board of Governors for Argonne National Laboratory, and Chair of the Searle Scholars Advisory Board. He has also been active as an entrepreneur. He is a Founder of 480 Biomedical, a company that has developed stents for the treatment of vessels in the leg and that are now in clinical trials. He is also Founder and Director of SAMDI Tech, a contract research organization that has commercialized his high throughput assays for discovering drug leads and that now serves global pharmaceutical companies. He has also served on a dozen Scientific Advisory Boards of other life sciences startup companies.

Meeting Co-Chairs
Dibakar Bhattacharyya (DB)
University of Kentucky
Isabel C. Escobar
University of Kentucky
Ingo Pinnau
King Abdullah University of Science & Technology